Showing 2 results for Hajikhani
M Keshtvarz, Mh Pourmand, Shirazi, M Yousefi, S Hajikhani,
Volume 8, Issue 1 (spring[PERSIAN] 2014)
Abstract
Abstract
Background and Objective: Transmission of pathogens by cosmetics is one of the major health complications. Direct contact with contaminated non-standard cosmetics can have irreparable side effects for the consumers. Thus, the evaluation of microbial contamination in cosmetic products is important. The aim of this study was to assess the microbiological contamination of one of frequently used cream.
Material and Methods: In the present study, 135 samples of a special moisturizing cream were randomly selected from pharmacies in Tehran. The microbial contamination assessment, sampling and culturing method were based on the protocol (No.3978) of Iranian Institute of Standard and Industrial Research.
Results: sixty-two (46%) out of 135 samples were contaminated. The highest and lowest contaminations observed were Pseudomonas aeruginosa and Bacillus, respectively.
Conclusion: Due to the high contamination rate of cosmetic creams, we recommend extremely monitoring and controlling these products by health centers.
Keywords: Cosmetics, Microbial Contamination, Pseudomonas Aeruginosa
Fatemeh Maghsood Ahmadi, Arash Arash Mahboubi, Farzaneh Hosseini, Davoud Esmaeili, Bahareh Hajikhani,
Volume 19, Issue 5 (9-2025)
Abstract
ABSTRACT
Background and objectives: Lactic acid bacteria (LAB) are potential candidates for the mucosal vaccine. Staphylococcal enterotoxin B (SEB), as a potent superantigen exotoxin is associated with widespread dietary poisoning and induction of toxic shock syndrome. Also, cholera toxin is the most important virulence factor in Vibrio cholera pathogenicity. CTB, a well-known immune adjuvant, enhances immunity and is mainly used to produce recombinant vaccines as antigen immunization enhancers. This study aimed to produce recombinant Lactobacillus Plantarum as a candidate vaccine against Vibrio cholera producing Cholera toxin and Staphylococcus aureus producing enterotoxin SEB. Methods: A gene sequence encoding SEB, devoid of superantigenic activity, and CTB were successfully designed, synthesized, cloned, and then expressed in a secreted form in the Lactobacillus Plantarum. The recombinant protein containing His-Tag was purified by Ni-NTA Agarose ion-exchange chromatography column. The purified protein was confirmed by Western blotting. Results: The result of this study demonstrated the expression of this recombinant protein in the Lactobacillus Plantarum system by pnz7021 expression vector. The protein electrophoresis showed that the molecular weight of recombinant fusion protein was 52 kDa. Western blot analysis also confirmed the production of recombinant protein. The use of recombinant vaccines has received a great deal of attention today. LP-pnz7021–SP-rseb-ctxB can be used as a suitable candidate in recombinant vaccines against Vibrio cholera producing Cholera toxin and Staphylococcus aureus producing enterotoxin SEB.